Develops antimicrobial disinfectants for food industry pathogens.
Apr 2026Revenue $2.42M/yrExpenses $4.33M/yr
No trendCash runway ≈ 7 months from Apr 2026
Figures by year
When will Pure Bioscience be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Apr 2026, revenue was $2.42M and expenses $4.33M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Jul 2025 | $2.20M | $4.47M | −$2.27M |
| Jul 2024 | $1.96M | $5.15M | −$3.19M |
| Jul 2023 | $1.87M | $5.81M | −$3.94M |
| Jul 2022 | $1.81M | $5.54M | −$3.72M |
| Jul 2021 | $3.70M | $6.01M | −$2.31M |
| Jul 2020 | $6.92M | $6.91M | $4.00K |
| Jul 2019 | $1.91M | $7.50M | −$5.59M |
| Jul 2018 | $1.77M | $8.82M | −$7.04M |
| Jul 2017 | $1.83M | $7.84M | −$6.01M |
| Jul 2012 | $812K | $9.57M | −$8.75M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.